Bath & Body Works price target raised to $50 from $45 at Argus

Argus analyst Taylor Conrad raised the firm’s price target on Bath & Body Works to $50 from $45 and keeps a Buy rating on the shares. To thrive in the current environment of increasing pressure from online retailers, companies need to have products that sell easily at brick-and-mortar stores and management teams that can make "quick merchandising decisions", and she contends that Bath & Body Works has these qualities, the analyst tells investors in a research note. Conrad adds that Bath & Body Work has performed well despite the slowdown in brick-and-mortar retail.